2,4-Dichloropyridine | CAS:26452-80-2

We serve 2,4-Dichloropyridine CAS:26452-80-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,4-Dichloropyridine

Chemical Name:2,4-Dichloropyridine
CAS.NO:26452-80-2
Synonyms:2,4-Dichloropyridine
Pyridine,2,4-dichloro
4,6-dichloropyridine
Molecular Formula:C5H3Cl2N
Molecular Weight:147.99000
 
Physical and Chemical Properties:
Density:1.37
Melting point:-1ºC
Boiling point:189-190ºC
Flash point:189-190ºC
Index of Refraction:1.55-1.554
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2,4-Dichloropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6-dichloropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6-dichloropyridine Use and application,4,6-dichloropyridine technical grade,usp/ep/jp grade.


Related News: With the onset of the DMF system for APIs, the concentration of the API industry will further increase.Iminodiacetonitrile manufacturer Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.glutaric acid supplier It has also sought to win acceptance for TCM overseas, establishing 30 overseas TCM centers in countries along the “Belt and Road Initiative,” Xi’s global infrastructure and investment program.1-fluoro-2-(trifluoromethoxy)benzene vendor It has also sought to win acceptance for TCM overseas, establishing 30 overseas TCM centers in countries along the “Belt and Road Initiative,” Xi’s global infrastructure and investment program.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.